Connolly, Anne
Wallman, Phoebe
Dzahini, Olubanke
Howes, Oliver
Taylor, David http://orcid.org/0000-0002-2557-1710
Article History
Received: 2 June 2023
Accepted: 23 October 2023
First Online: 19 January 2024
Declarations
:
: DT has received research funding from Janssen and speaking honoraria from Janssen, Viatris and Otsuka. OH is a part-time employee and stock-holder of H Lundbeck A/s and has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organised by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Heptares, Global Medical Education, Invicro, Jansenn, Lundbeck, Neurocrine, Otsuka, Sunovion, Recordati, Roche and Viatris/Mylan. OH has a patent for the use of dopaminergic imaging. The remaining authors declare no conflict of interest.